Dr Irfan Khan joined AKU-CRM on a joint appointment with the Department of Ophthalmology & Visual Sciences in March 2024. He has more than 11 years of experience in the field of molecular medicine, stem cells and tissue engineering research. His research interests focus on understanding and treating retinal and optic nerve degenerative disorders. At AKU-CRM he is leveraging his efforts to develop a rapid differentiation protocol using a 3D retinal organoid model to investigate signaling and transcription factors in retinal ganglion cells fate specification.
